Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Rallybio Corporation
13G/A
RLYB · 75120L209
|
2.9% |
4/13/2026
Event 3/31/2026
|
|||
| Johnson & Johnson | 2.9% | ||||
| Johnson & Johnson Innovation - JJDC, Inc. | 2.9% | ||||
|
CVRx, Inc.
13G/A
CVRX · 126638105
|
15.4% |
1/12/2026
Event 12/31/2025
|
|||
| Johnson & Johnson | 15.4% | ||||
| Johnson & Johnson Innovation - JJDC, Inc. | 15.4% | ||||
|
Rapport Therapeutics, Inc.
13G/A
RAPP · 75383L102
|
4.9% |
10/22/2025
Event 9/30/2025
|
|||
| Johnson & Johnson | 4.9% | ||||
| Johnson & Johnson Innovation - JJDC, Inc. | 4.9% | ||||